Ossiam Merck & Co., Inc. Transaction History

Ossiam

$5.65 Billion
Q1 2024

A detailed history of Ossiam transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ossiam holds 113,569 shares of MRK stock, worth $14.5 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

113,569

Previous 552,025 79.43%

Holding current value

$14.5 Million

Previous $60.2 Million 75.1%

% of portfolio

0.27%

Previous 0.97%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$113.24 - $131.95 $49.7 Million - $57.9 Million	-438,456 Reduced 79.43%	113,569 $15 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $47.2 Million - $51.3 Million	470,962 Added 580.98%	552,025 $60.2 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $13.9 Million - $15.4 Million	-134,833 Reduced 62.45%	81,063 $8.35 Million
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $12.7 Million - $13.9 Million	117,002 Added 118.31%	215,896 $24.9 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $28.9 Million - $32.3 Million	-281,005 Reduced 73.97%	98,894 $10.5 Million

Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $1.65 Million - $2.12 Million	18,879 Added 5.23%	379,899 $42.1 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $20.2 Million - $22.7 Million	239,193 Added 196.34%	361,020 $31.1 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $4.39 Million - $4.98 Million	-52,582 Reduced 30.15%	121,827 $11.1 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $11.5 Million - $12.9 Million	156,134 Added 854.36%	174,409 $14.3 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $2.76 Million - $3.46 Million	-38,232 Reduced 67.66%	18,275 $1.4 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $2.47 Million - $2.72 Million	34,503 Added 156.8%	56,507 $4.24 Million
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $2.28 Million - $2.52 Million	-32,363 Reduced 59.53%	22,004 $1.69 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $15.7 Million - $18.5 Million	-228,552 Reduced 80.78%	54,367 $4.19 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $19.2 Million - $21.3 Million	267,922 Added 1786.5%	282,919 $23.1 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $948,485 - $1.08 Million	-12,961 Reduced 46.36%	14,997 $1.24 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $928,558 - $1.06 Million	-13,186 Reduced 32.05%	27,958 $2.16 Million
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $2 Million - $2.78 Million	31,633 Added 332.59%	41,144 $3.17 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $1.49 Million - $1.68 Million	-19,199 Reduced 66.87%	9,511 $865,000
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $2.98 Million - $3.25 Million	-39,199 Reduced 57.72%	28,710 $2.42 Million
Q2 2019 Aug 13, 2019	BUY	$69.84 - $81.59 $1.04 Million - $1.21 Million	14,821 Added 27.92%	67,909 $5.69 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $6.27 Million - $7.15 Million	-90,073 Reduced 62.92%	53,088 $4.42 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $9.34 Million - $10.8 Million	143,161 New	143,161 $10.9 Million

Others Institutions Holding MRK

# of Institutions

3,767

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $324B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.

Account